Psychedelics

The Pharmacy Times® Psychedelics Resource Center is a comprehensive resource for clinical news and expert insights on issues related to psychedelic medicine, which includes drugs such as psilocybin, MDMA, LSD, and ketamine, among others. Although not commonly identified as a psychedelic medicine, cannabis can also be included in this category.

Latest News

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment

October 4th 2024

When considering the 3-stage framework, perhaps a greater emphasis on pre-treatment phase research could help identify some of the more individual traits used to better predict patient outcomes.

Doctor writing on prescription blank and bottle with medical cannabis on table close up - Image credit: Africa Studio | stock.adobe.com
A Pharmacist’s Guide to Medical Cannabis Interactions and Patient Care

September 13th 2024

From Opioids to Cannabis: The Impact of Rescheduling on Pharmacy Revenue Streams
From Opioids to Cannabis: The Impact of Cannabis Rescheduling on Pharmacy Revenue Streams

September 11th 2024

Psychedelics, Pharmacy FDA | Image Credit: Araki Illustrations - stock.adobe.com
FDA Declines to Approve MDMA for PTSD

August 9th 2024

Wooden tiles spelling ketamine -- Image credit: lexiconimages | stock.adobe.com
Slow-Release, Oral Ketamine Tablet May Reduce Severity of Treatment-Resistant Depression

July 9th 2024

Video Interviews
Podcasts

More News